Tectonic Therapeutic, Inc. (TECX) stock

TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30

$21.96−0.01 (-0.05%)

Close on Nov 11, 2026Market cap $429.30MP/E –Yield 0.00%

Tectonic Therapeutic statistics

69 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Q3 FY2026, expected soon
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 11, 2026

Valuation ratiosIndustry

Market Cap: $429.30M; $282.97M
Enterprise Value: $194.64M; $154.96M
PB Ratio: 1.87; 2.17
P/TBV Ratio: 1.87; 2.39

Share statisticsIndustry

Shares Outstanding: 20M; 58M
Shares Change (YoY): 9.76%; 10.9%
Shares Change (QoQ): 3.64%; 0.51%
Float: 11M; 49M
Shares Held by Insiders: 42.8%; 11.6%
Shares Held by Institutions: 71.4%; 56.4%

Short sellingIndustry

Short Interest: 2M; –
Short Interest Change: 6.79%; -0.76%
Short % of Float: 21.2%; 9.06%
Short % of Shares Outstanding: 12.2%; 6.38%
Days to Cover: 13.66; 5.16

Stock price statisticsIndustry

52-Week High: $39.53; –
52-Week Low: $16.77; –
20-Day Moving Average: $20.66; –
50-Day Moving Average: $23.67; –
200-Day Moving Average: $28.13; –
Average True Range (14): $1.32; –
Price Change (1 Week): 8.18%; -0.50%
Price Change (1 Month): 3.05%; -0.33%
Price Change (3 Months): -35.4%; -17.2%
Price Change (6 Months): -23.8%; -20.1%
Price Change (YTD): 5.27%; -20.1%
Price Change (1 Year): 16.3%; -19.3%
Price Change (3 Years): 33.6%; -23.4%
Price Change (5 Years): -65.6%; -76.4%
Average Volume (10 Days): 176,717; –
Average Volume (20 Days): 181,037; –
Average Volume (90 Days): 208,261; –
Relative Volume: 0.64; 0.73
Relative Strength Index (14): 52.0; 47.6
Volatility (1 Year): 71.7%; 80.2%
Beta (5 Years): 1.55; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -35.5%; -51.3%
Return on Assets (ROA): -33.8%; -40.3%
Return on Capital Employed (ROCE): -41.6%; -37.7%

Financial positionIndustry

Current Ratio: 19.71; 3.30
Quick Ratio: 19.39; 2.37
Interest Coverage: -3216.43; -6.27

EfficiencyIndustry

Profits Per Employee: -$1.47M; -$680.86K
Employee Count: 60; 75
WACC: 12.6%; 10.1%

Income statement (TTM)Industry

Operating Income: -$96.49M; -$20.20M
Net Income: -$88.10M; -$21.57M
EBITDA: -$95.32M; -$16.36M
EPS (Diluted): -$4.63; -$0.77

Balance sheetIndustry

Cash & Short-Term Investments: $234.67M; $65.30M
Net Cash (Debt): $234.67M; $16.31M
Net Cash Per Share: $12.00; $0.70
Equity (Book Value): $229.33M; $53.12M
Book Value Per Share: $11.73; $1.49
Tangible Book Value: $229.33M; $26.11M
Working Capital: $226.45M; $77.59M

Cash flow (TTM)Industry

Operating Cash Flow: -$69.23M; -$12.07M
Capital Expenditures: -$98.00K; -$939.00K
Free Cash Flow: -$69.33M; -$18.37M
FCF Per Share: -$3.55; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -20.5%; -19.8%
FCF Yield: -16.1%; -8.81%
Dividend Yield: 0.00%; 1.86%
Shareholder Yield: 0.00%; 0.00%
Dividend Per Share: $0.00; $0.83
Years of Dividend Growth: 0; 0

Taxes and interestIndustry

Interest Expense: $30.00K; $2.98M

Scores and fair valueIndustry

Altman Z-Score: 15.86; 0.28
Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

Period	TECX	S&P 500	Difference	TECX per year	S&P 500 per year
1 month	-5.9%	-2.4%	−3.5 pts
3 months	-31.1%	-1.2%	−29.9 pts
Year to date	+5.3%	+12.3%	−7.0 pts
1 year	+15.7%	+12.4%	+3.3 pts
3 years	+33.6%	+78.8%	−45.2 pts	+10.1%	+21.4%
5 years	-65.8%	+75.2%	−141.0 pts	-19.3%	+11.9%
10 years	+18200.0%	+311.1%	+17888.9 pts	+68.4%	+15.2%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M TECX shares were sold short on Oct 30, 2026, up 6.8% from the previous report, or 21.23% of the shares available to trade. At recent volumes it would take 13.7 days to buy them back. Over the last 20 sessions, 57.6% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	2,375,596	+6.8%	173,921	13.7
Oct 15, 2026	2,224,634	+0.1%	210,279	10.6
Sep 30, 2026	2,222,184	+0.2%	275,508	8.1
Sep 15, 2026	2,218,549	+14.2%	170,592	13.0
Aug 31, 2026	1,942,426	+12.5%	255,869	7.6
Aug 14, 2026	1,726,909	-2.2%	204,884	8.4
Jul 31, 2026	1,764,899	-8.9%	164,029	10.8
Jul 15, 2026	1,936,691	-9.4%	255,529	7.6
Jun 30, 2026	2,136,671	-0.7%	149,301	14.3
Jun 15, 2026	2,152,242	-8.1%	129,301	16.6
May 29, 2026	2,341,074	-10.4%	221,016	10.6
May 15, 2026	2,612,024	+6.5%	255,380	10.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?